Recruiting

Drain Care

Sponsor:

University of Missouri-Columbia

Code:

NCT05846438

Conditions

Infections

Quality of Life

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Showering 48 hours after surgery

Study Details

Brief summary:

The goal of this clinical trial is to learn whether showering with surgical drain tubes in place after first stage breast reconstruction causes increased risk of infection. The main questions it aims to answer are:

  • Is there an increased risk of infection/complications with showering 48 hours after drain tubes are in place
  • Does showering after 48 hours with drain tubes in place affect quality of life.

Conditions

Infections

Quality of Life

Study ID

NCT05846438

Start date

Mar 15, 2023

Status verified date

Apr, 2026

Completion date

Mar 15, 2028

Anticipated

Primary completion date

Mar 15, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • undergoing breast surgery with placement of tissue expander and drains, acceptance of protocol and procedures, age > 18

Exclusion Criteria:

  • no existing wounds, previous infections related to implant device if delayed, refusal by patient

Study Design

Enrollment

100 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Showering 48 hours after Surgery

Group 1 will be allowed to shower 48 hours after surgery with drain tubes still in place.

no intervention: Showering after drain tubes are removed

Group 2 will not be allowed to shower until drain tubes are removed.

Interventions

Showering 48 hours after surgery

The main intervention is allowing patients to shower 48 hours after surgery

Primary outcome measure

  • Presence of Post Operative Infection [ Time Frame: 90 days ]

Central Contacts and Locations

Locations

University of Missouri

Recruiting

Columbia, Missouri, United States, 65212

Contacts

Principal Investigator:

Stephen Colbert, MD

More Information

Sponsor

University of Missouri-Columbia

Last update posted

May 5, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Missouri-Columbia on 2026-05-05.